796 related articles for article (PubMed ID: 21294723)
21. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
Lewinsohn DM; Zhu L; Madison VJ; Dillon DC; Fling SP; Reed SG; Grabstein KH; Alderson MR
J Immunol; 2001 Jan; 166(1):439-46. PubMed ID: 11123322
[TBL] [Abstract][Full Text] [Related]
22. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
[TBL] [Abstract][Full Text] [Related]
23. Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
Suzuki M; Aoshi T; Nagata T; Koide Y
Infect Immun; 2004 Jul; 72(7):3829-37. PubMed ID: 15213124
[TBL] [Abstract][Full Text] [Related]
24. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
[TBL] [Abstract][Full Text] [Related]
25. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
[TBL] [Abstract][Full Text] [Related]
26. Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening.
Aoshi T; Nagata T; Suzuki M; Uchijima M; Hashimoto D; Rafiei A; Suda T; Chida K; Koide Y
Infect Immun; 2008 Apr; 76(4):1565-71. PubMed ID: 18212086
[TBL] [Abstract][Full Text] [Related]
27. Identification of Mycobacterium tuberculosis CTL epitopes restricted by HLA-A*0201 in HHD mice.
Rafiei A; Kiutade Y
Iran Biomed J; 2007 Jan; 11(1):23-31. PubMed ID: 18051701
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
Fonseca DP; Joosten D; Snippe H; Verheul AF
Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876
[TBL] [Abstract][Full Text] [Related]
29. HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis.
Chaitra MG; Shaila MS; Chandra NR; Nayak R
Scand J Immunol; 2008 Apr; 67(4):411-7. PubMed ID: 18248530
[TBL] [Abstract][Full Text] [Related]
30. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.
Geluk A; Taneja V; van Meijgaarden KE; Zanelli E; Abou-Zeid C; Thole JE; de Vries RR; David CS; Ottenhoff TH
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10797-802. PubMed ID: 9724784
[TBL] [Abstract][Full Text] [Related]
31. Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.
Caccamo N; Pietra G; Sullivan LC; Brooks AG; Prezzemolo T; La Manna MP; Di Liberto D; Joosten SA; van Meijgaarden KE; Di Carlo P; Titone L; Moretta L; Mingari MC; Ottenhoff TH; Dieli F
Eur J Immunol; 2015 Apr; 45(4):1069-81. PubMed ID: 25631937
[TBL] [Abstract][Full Text] [Related]
32. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.
Tully G; Kortsik C; Höhn H; Zehbe I; Hitzler WE; Neukirch C; Freitag K; Kayser K; Maeurer MJ
J Immunol; 2005 Feb; 174(4):2174-84. PubMed ID: 15699149
[TBL] [Abstract][Full Text] [Related]
33. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
34. High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.
Wang M; Tang ST; Lund O; Dziegiel MH; Buus S; Claesson MH
Clin Exp Immunol; 2009 Mar; 155(3):441-6. PubMed ID: 19220834
[TBL] [Abstract][Full Text] [Related]
35. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.
Kuzushima K; Hayashi N; Kimura H; Tsurumi T
Blood; 2001 Sep; 98(6):1872-81. PubMed ID: 11535524
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.
Cho S; Mehra V; Thoma-Uszynski S; Stenger S; Serbina N; Mazzaccaro RJ; Flynn JL; Barnes PF; Southwood S; Celis E; Bloom BR; Modlin RL; Sette A
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12210-5. PubMed ID: 11035787
[TBL] [Abstract][Full Text] [Related]
37. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
[TBL] [Abstract][Full Text] [Related]
38. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
39. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
